Daniel Lynch, Director: SpringWorks Therapeutics SWTX Sell · Filed 25/02/24

Trade details

Type: Insider sale
Amount: $2,647,242.52
Shares · price: 44,018 sh · $60.14 a share
Held after: 86,526 sh
Stock: SpringWorks Therapeutics SWTX
Person: Daniel LynchDirector
Trade date: 25/02/20
Filed: 25/02/24
Days to filing: 4 days

Sold 33.7% of holdings

Share of holding sold: 33.7%

SpringWorks Therapeutics trades, last 26 weeks

What else happened in SpringWorks Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/21~25/03/22

Daniel Lynch's recent trades

Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$219.4K
3,582 sh
$219.4K
Filed 25/02/24
Traded 25/02/20
Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$24K
400 sh
$24K
Filed 25/02/19
Traded 25/02/14
Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$3.7M
69,766 sh
$3.7M
Filed 25/02/12
Traded 25/02/10
Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$3.6M
65,600 sh
$3.6M
Filed 25/02/12
Traded 25/02/10
Daniel LynchDirector
Sell10b5-1 planSpringWorks Therapeutics
Sell10b5-1 plan
SpringWorks Therapeutics
SWTX
$2.2M
39,634 sh
$2.2M
Filed 25/02/12
Traded 25/02/10

Daniel Lynch, Director — sold $2.6M of SpringWorks Therapeutics SWTX · 33.7% of holdings · 10b5-1 plan | Whalegun